US5916891A
(en)
|
1992-01-13 |
1999-06-29 |
Smithkline Beecham Corporation |
Pyrimidinyl imidazoles
|
ES2053401B1
(es)
*
|
1992-01-13 |
1995-03-01 |
Smithkline Beecham Corp |
Compuestos de imidazol y procedimientos para su prepacion.
|
US5593992A
(en)
*
|
1993-07-16 |
1997-01-14 |
Smithkline Beecham Corporation |
Compounds
|
IL110296A
(en)
*
|
1993-07-16 |
1999-12-31 |
Smithkline Beecham Corp |
Imidazole compounds process for their preparation and pharmaceutical compositions containing them
|
US5783664A
(en)
*
|
1993-09-17 |
1998-07-21 |
Smithkline Beecham Corporation |
Cytokine suppressive anit-inflammatory drug binding proteins
|
US5922751A
(en)
|
1994-06-24 |
1999-07-13 |
Euro-Celtique, S.A. |
Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
|
ES2208698T3
(es)
*
|
1994-12-13 |
2004-06-16 |
F. Hoffmann-La Roche Ag |
Derivados de imidazol.
|
MX9705296A
(es)
*
|
1995-01-12 |
1997-10-31 |
Smithkline Beecham Corp |
Compuestos novedosos de imidazol 1,4,5-susbtituidos y el uso de los mismos para preparar composiciones para uso en terapia.
|
US5700826A
(en)
*
|
1995-06-07 |
1997-12-23 |
Ontogen Corporation |
1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance
|
KR100284382B1
(ko)
|
1995-08-22 |
2001-03-02 |
미즈노 마사루 |
아미드화합물 및 그의 용도
|
US5717100A
(en)
*
|
1995-10-06 |
1998-02-10 |
Merck & Co., Inc. |
Substituted imidazoles having anti-cancer and cytokine inhibitory activity
|
IL123950A
(en)
*
|
1995-10-06 |
2001-04-30 |
Merck & Co Inc |
Transformed imidazoles with anti-cancer and cytokine-inhibiting activity and pharmaceutical preparations containing them
|
US6083949A
(en)
*
|
1995-10-06 |
2000-07-04 |
Merck & Co., Inc. |
Substituted imidazoles having anti-cancer and cytokine inhibitory activity
|
EP0859771A4
(en)
*
|
1995-10-31 |
2000-03-15 |
Merck & Co Inc |
SUBSTITUTED PYRIDYL PYRROLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHOD OF USE
|
ZA9610687B
(en)
*
|
1995-12-22 |
1997-09-29 |
Smithkline Beecham Corp |
Novel synthesis.
|
AP9700912A0
(en)
|
1996-01-11 |
1997-01-31 |
Smithkline Beecham Corp |
Novel cycloalkyl substituted imidazoles
|
US6046208A
(en)
*
|
1996-01-11 |
2000-04-04 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
US5756499A
(en)
*
|
1996-01-11 |
1998-05-26 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
JP2000507224A
(ja)
|
1996-03-08 |
2000-06-13 |
スミスクライン・ビーチャム・コーポレイション |
Csaid化合物の血管形成の抑制物質としての使用
|
JP2000506532A
(ja)
*
|
1996-03-13 |
2000-05-30 |
スミスクライン・ビーチャム・コーポレイション |
サイトカイン介在疾患の治療にて有用な新規ピリミジン化合物
|
US6096739A
(en)
*
|
1996-03-25 |
2000-08-01 |
Smithkline Beecham Corporation |
Treatment for CNS injuries
|
EP0889887A4
(en)
*
|
1996-03-25 |
2003-06-11 |
Smithkline Beecham Corp |
TREATMENT OF CENTRAL NERVOUS SYSTEM INJURIES
|
US6294541B1
(en)
|
1996-06-06 |
2001-09-25 |
Euro-Celtique S.A. |
Purine derivatives having phosphodiesterase IV inhibition activity
|
JP3418624B2
(ja)
*
|
1996-06-10 |
2003-06-23 |
メルク エンド カンパニー インコーポレーテッド |
サイトカイン阻害活性を有する置換イミダゾール類
|
WO1998007425A1
(en)
|
1996-08-21 |
1998-02-26 |
Smithkline Beecham Corporation |
Imidazole compounds, compositions and use
|
US5744473A
(en)
*
|
1996-09-16 |
1998-04-28 |
Euro-Celtique, S.A. |
PDE IV inhibitors: "bis-compounds"
|
HUP9903330A2
(hu)
|
1996-11-19 |
2000-03-28 |
Amgen Inc. |
Gyulladásgátló hatású, aril- és heteroaril csoporttal szubsztituált kondenzált pirrolszármazékok, valamint ezeket tartalmazó gyógyászati készítmények
|
WO1998022108A1
(en)
*
|
1996-11-20 |
1998-05-28 |
Merck & Co., Inc. |
Triaryl substituted imidazoles and methods of use
|
EP0959886A4
(en)
*
|
1996-11-20 |
2001-05-02 |
Merck & Co Inc |
TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS
|
US5880139A
(en)
*
|
1996-11-20 |
1999-03-09 |
Merck & Co., Inc. |
Triaryl substituted imidazoles as glucagon antagonists
|
CA2271963A1
(en)
*
|
1996-11-20 |
1998-05-28 |
Linda L. Chang |
Triaryl substituted imidazoles, compositions containing such compounds and methods of use
|
US6410729B1
(en)
|
1996-12-05 |
2002-06-25 |
Amgen Inc. |
Substituted pyrimidine compounds and methods of use
|
US6096753A
(en)
|
1996-12-05 |
2000-08-01 |
Amgen Inc. |
Substituted pyrimidinone and pyridone compounds and methods of use
|
US5929076A
(en)
*
|
1997-01-10 |
1999-07-27 |
Smithkline Beecham Corporation |
Cycloalkyl substituted imidazoles
|
KR100568438B1
(ko)
|
1997-04-24 |
2006-04-07 |
오르토-맥네일 파마슈티칼, 인코퍼레이티드 |
염증성 질환의 치료에 유용한 치환된 이미다졸, 이의 제조방법 및 이를 포함하는 약제학적 조성물
|
DK0988301T3
(da)
|
1997-06-12 |
2006-11-13 |
Aventis Pharma Ltd |
Imidazolylcykliske acetaler
|
AU7966198A
(en)
|
1997-06-13 |
1998-12-30 |
Smithkline Beecham Corporation |
Novel pyrazole and pyrazoline substituted compounds
|
JP2002505690A
(ja)
|
1997-06-19 |
2002-02-19 |
スミスクライン・ビーチャム・コーポレイション |
新規なアリールオキシピリミジン置換イミダゾール化合物
|
GB9713726D0
(en)
|
1997-06-30 |
1997-09-03 |
Ciba Geigy Ag |
Organic compounds
|
IL133766A0
(en)
*
|
1997-06-30 |
2001-04-30 |
Ortho Mcneil Pharm Inc |
2-substituted imidazoles useful in the treatment of inflammatory diseases
|
EP1019396A1
(en)
|
1997-07-02 |
2000-07-19 |
SmithKline Beecham Corporation |
Novel cycloalkyl substituted imidazoles
|
US7301021B2
(en)
|
1997-07-02 |
2007-11-27 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
US6562832B1
(en)
|
1997-07-02 |
2003-05-13 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
US6489325B1
(en)
|
1998-07-01 |
2002-12-03 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
TW517055B
(en)
|
1997-07-02 |
2003-01-11 |
Smithkline Beecham Corp |
Novel substituted imidazole compounds
|
US5840721A
(en)
*
|
1997-07-09 |
1998-11-24 |
Ontogen Corporation |
Imidazole derivatives as MDR modulators
|
JP2001518507A
(ja)
|
1997-10-08 |
2001-10-16 |
スミスクライン・ビーチャム・コーポレイション |
新規シクロアルケニル置換化合物
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
ID24166A
(id)
|
1997-11-19 |
2000-07-13 |
Kowa Co |
Turunan piridazin baru dan obat-obatan yang mengandung hal yang sama sebagai ramuan efektif
|
CA2313004A1
(en)
|
1997-12-12 |
1999-06-24 |
David Cavalla |
3-substituted adenines via2-thioxanthines
|
JP2001526230A
(ja)
|
1997-12-19 |
2001-12-18 |
スミスクライン・ビーチャム・コーポレイション |
ヘテロアリール置換イミダゾール化合物、その医薬組成物および使用
|
WO1999043680A1
(en)
*
|
1998-02-26 |
1999-09-02 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted pyrrolobenzimidazoles for treating inflammatory diseases
|
IL139732A0
(en)
|
1998-05-22 |
2002-02-10 |
Smithkline Beecham Corp |
Novel 2-alkyl substituted imidazole compounds
|
US6858617B2
(en)
|
1998-05-26 |
2005-02-22 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
JP4588215B2
(ja)
*
|
1998-06-24 |
2010-11-24 |
ユニバーシティー オブ ダンディー |
ポリペプチド、ポリヌクレオチド及びそれらの用途
|
AU4395399A
(en)
*
|
1998-07-02 |
2000-01-24 |
Sankyo Company Limited |
Five-membered heteroaryl compounds
|
ATE266399T1
(de)
*
|
1998-08-20 |
2004-05-15 |
Smithkline Beecham Corp |
Neue substituierte triazolverbindungen
|
NZ510308A
(en)
|
1998-09-09 |
2003-06-30 |
Metabasis Therapeutics Inc |
Heteroaromatic alkylene substituted phosphonate derivatives useful as inhibitors of Fructose 1,6-bisphosphatase
|
DE19842833B4
(de)
*
|
1998-09-18 |
2005-04-14 |
Merckle Gmbh |
2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung
|
AU1909200A
(en)
|
1998-11-04 |
2000-05-22 |
Smithkline Beecham Corporation |
Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
|
US6319928B1
(en)
|
1998-11-30 |
2001-11-20 |
Euro-Celtique, S.A. |
Purine derivatives having phosphodiesterase IV inhibition activity
|
US6239279B1
(en)
*
|
1998-12-16 |
2001-05-29 |
Smithkline Beecham Corporation |
Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives
|
EP1140083A4
(en)
|
1999-01-08 |
2004-01-02 |
Smithkline Beecham Corp |
NEW CONNECTIONS
|
UA73492C2
(en)
*
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
WO2000050425A1
(en)
|
1999-02-22 |
2000-08-31 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Polycyclo heterocyclic derivatives as antiinflammatory agents
|
JP2000247959A
(ja)
|
1999-02-26 |
2000-09-12 |
Kowa Co |
ピリダジン−3−オン誘導体及びこれを含有する医薬
|
MXPA01009077A
(es)
|
1999-03-12 |
2002-03-27 |
Boehringer Ingelheim Pharma |
Composiciones heterociclicos aromaticos como agentes anti-inflamatorios.
|
CN1511830A
(zh)
|
1999-03-12 |
2004-07-14 |
���ָ��.Ӣ��ķҩ�﹫˾ |
作为消炎剂的化合物
|
CN1377353A
(zh)
|
1999-04-02 |
2002-10-30 |
欧罗赛铁克股份有限公司 |
具有磷酸二酯酶iv抑制活性的嘌呤衍生物
|
WO2000066124A1
(fr)
*
|
1999-04-28 |
2000-11-09 |
Sankyo Company, Limited |
Agents preventifs ou inhibiteurs destines a une hepatopathie
|
PT1178981E
(pt)
|
1999-05-14 |
2003-11-28 |
Ortho Mcneil Pharm Inc |
3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
|
ES2253233T3
(es)
*
|
1999-07-09 |
2006-06-01 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Procedimiento para sintesis de compuestos de urea heteroaril sustituidos.
|
CN1255406C
(zh)
|
1999-11-10 |
2006-05-10 |
奥索-麦克尼尔药品公司 |
取代的2-芳基-3-(杂芳基)-咪唑并[1,2-a]嘧啶类化合物以及相关的药物组合物和方法
|
US6808902B1
(en)
|
1999-11-12 |
2004-10-26 |
Amgen Inc. |
Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
|
JP2003528043A
(ja)
|
1999-11-23 |
2003-09-24 |
スミスクライン・ビーチャム・コーポレイション |
CSBP/p38キナーゼ阻害剤としての3,4‐ジヒドロ−(1H)キナゾリン−2−オン化合物
|
EP1233951B1
(en)
|
1999-11-23 |
2005-06-01 |
SmithKline Beecham Corporation |
3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
|
US6759410B1
(en)
|
1999-11-23 |
2004-07-06 |
Smithline Beecham Corporation |
3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
|
US7053099B1
(en)
|
1999-11-23 |
2006-05-30 |
Smithkline Beecham Corporation |
3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors
|
US6525046B1
(en)
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
CO5271680A1
(es)
*
|
2000-02-21 |
2003-04-30 |
Smithkline Beecham Corp |
Compuestos
|
US7235551B2
(en)
|
2000-03-02 |
2007-06-26 |
Smithkline Beecham Corporation |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
|
GB0007405D0
(en)
*
|
2000-03-27 |
2000-05-17 |
Smithkline Beecham Corp |
Compounds
|
WO2001074811A2
(en)
*
|
2000-03-30 |
2001-10-11 |
Takeda Chemical Industries, Ltd. |
Substituted 1,3-thiazole compounds, their production and use
|
US7563774B2
(en)
|
2000-06-29 |
2009-07-21 |
Metabasis Therapeutics, Inc. |
Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
|
US6664256B1
(en)
|
2000-07-10 |
2003-12-16 |
Kowa Co., Ltd. |
Phenylpyridazine compounds and medicines containing the same
|
ATE297392T1
(de)
|
2000-10-18 |
2005-06-15 |
Ortho Mcneil Pharm Inc |
Substituierte imidazole, die sich für die behandlung entzündlicher krankheiten eignen
|
KR100850812B1
(ko)
|
2000-10-23 |
2008-08-06 |
스미스클라인 비참 코포레이션 |
신규 화합물
|
EP1354603A1
(en)
*
|
2000-12-26 |
2003-10-22 |
Takeda Chemical Industries, Ltd. |
Concomitant drugs
|
DE60223339T2
(de)
*
|
2001-01-22 |
2008-08-28 |
Sankyo Co., Ltd. |
Durch bicyclische aminogruppen substituierte verbindungen
|
DE10107683A1
(de)
|
2001-02-19 |
2002-08-29 |
Merckle Gmbh Chem Pharm Fabrik |
2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
|
US6790846B2
(en)
*
|
2001-05-24 |
2004-09-14 |
The Procter & Gamble Company |
Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity
|
PT2087908T
(pt)
|
2001-06-26 |
2018-07-16 |
Amgen Inc |
Anticorpos contra opgl
|
CA2465759A1
(en)
*
|
2001-12-11 |
2003-06-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Method for administering birb 796 bs
|
WO2003072569A1
(en)
*
|
2002-02-25 |
2003-09-04 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
|
WO2003080179A1
(fr)
|
2002-03-27 |
2003-10-02 |
Nippon Sigmax Co., Ltd. |
Dispositif de regulation de cytokines, dispositif de traitement et procede de traitement
|
AR039241A1
(es)
|
2002-04-04 |
2005-02-16 |
Biogen Inc |
Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
|
CA2492033A1
(en)
|
2002-07-09 |
2004-01-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
|
AU2003256297A1
(en)
*
|
2002-08-09 |
2004-02-25 |
Eli Lilly And Company |
Benzimidazoles and benzothiazoles as inhibitors of map kinase
|
CN101899006B
(zh)
|
2002-08-19 |
2013-11-06 |
劳洛斯治疗公司 |
2,4,5-三取代的咪唑及其作为抗菌剂的用途
|
DE10238045A1
(de)
*
|
2002-08-20 |
2004-03-04 |
Merckle Gmbh Chem.-Pharm. Fabrik |
2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
|
UA80295C2
(en)
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Pyrazolopyridines and using the same
|
WO2004060911A2
(en)
|
2002-12-30 |
2004-07-22 |
Amgen Inc. |
Combination therapy with co-stimulatory factors
|
WO2004063192A1
(en)
*
|
2003-01-10 |
2004-07-29 |
Pharmacopeia Drug Discovery, Inc. |
Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
|
CL2004000234A1
(es)
*
|
2003-02-12 |
2005-04-15 |
Biogen Idec Inc |
Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid
|
CL2004000366A1
(es)
*
|
2003-02-26 |
2005-01-07 |
Pharmacia Corp Sa Organizada B |
USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
|
WO2004083188A1
(ja)
|
2003-03-18 |
2004-09-30 |
Kowa Co., Ltd. |
水溶性フェニルピリダジン誘導体及びこれを含有する医薬
|
CA2545942C
(en)
|
2003-11-14 |
2012-07-10 |
Lorus Therapeutics Inc. |
Aryl imidazoles and their use as anti-cancer agents
|
EP2284157A1
(en)
|
2003-12-12 |
2011-02-16 |
Wyeth |
Quinolines useful in treating cardiovascular disease
|
AU2004308932A1
(en)
*
|
2003-12-22 |
2005-07-14 |
Amgen Inc |
Aryl sulfonamide compounds and uses related thereto
|
TWI332003B
(en)
*
|
2004-01-30 |
2010-10-21 |
Lilly Co Eli |
Kinase inhibitors
|
US20060035893A1
(en)
|
2004-08-07 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
WO2006068760A2
(en)
|
2004-11-19 |
2006-06-29 |
The Regents Of The University Of California |
Anti-inflammatory pyrazolopyrimidines
|
US20080119498A1
(en)
*
|
2004-12-06 |
2008-05-22 |
Masatomo Kato |
Therapeutic Agent for Pruritus Comprising P38 Map Kinase Inhibitor as the Active Ingredient
|
PE20060777A1
(es)
|
2004-12-24 |
2006-10-06 |
Boehringer Ingelheim Int |
Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
|
KR101181692B1
(ko)
|
2004-12-28 |
2012-09-19 |
아스카 세이야쿠 가부시키가이샤 |
피리미디닐이속사졸 유도체
|
KR101327323B1
(ko)
*
|
2005-01-14 |
2013-11-11 |
에스케이바이오팜 주식회사 |
옥사졸 하이드록삼산 유도체 및 이들의 용도
|
PE20100737A1
(es)
*
|
2005-03-25 |
2010-11-27 |
Glaxo Group Ltd |
Nuevos compuestos
|
US8148392B2
(en)
*
|
2005-05-25 |
2012-04-03 |
Lorus Therapeutics Inc. |
2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use in the treatment of cancer
|
TW200804288A
(en)
*
|
2005-12-12 |
2008-01-16 |
Astrazeneca Ab |
Alkylsulphonamide quinolines
|
MX2008012928A
(es)
|
2006-04-04 |
2009-03-06 |
Univ California |
Antagonistas de pi3-cinasa.
|
WO2008001929A1
(fr)
|
2006-06-28 |
2008-01-03 |
Aska Pharmaceutical Co., Ltd. |
Agent de traitement pour la maladie intestinale inflammatoire
|
KR101412943B1
(ko)
|
2006-06-28 |
2014-06-26 |
아스카 세이야쿠 가부시키가이샤 |
피리딜이소옥사졸 유도체
|
JP4588791B2
(ja)
|
2007-02-16 |
2010-12-01 |
あすか製薬株式会社 |
微粒子油性懸濁液を含む医薬組成物
|
WO2008133192A1
(ja)
*
|
2007-04-19 |
2008-11-06 |
Takeda Pharmaceutical Company Limited |
縮合イミダゾール化合物およびその用途
|
EP1992344A1
(en)
|
2007-05-18 |
2008-11-19 |
Institut Curie |
P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
|
GB2467670B
(en)
|
2007-10-04 |
2012-08-01 |
Intellikine Inc |
Chemical entities and therapeutic uses thereof
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
CN101965336B
(zh)
|
2008-01-04 |
2015-06-17 |
英特利凯恩有限责任公司 |
某些化学实体、组合物和方法
|
US8993580B2
(en)
|
2008-03-14 |
2015-03-31 |
Intellikine Llc |
Benzothiazole kinase inhibitors and methods of use
|
WO2009114870A2
(en)
|
2008-03-14 |
2009-09-17 |
Intellikine, Inc. |
Kinase inhibitors and methods of use
|
US20110224223A1
(en)
|
2008-07-08 |
2011-09-15 |
The Regents Of The University Of California, A California Corporation |
MTOR Modulators and Uses Thereof
|
CA2730106A1
(en)
|
2008-07-08 |
2010-01-14 |
Intellikine, Inc. |
Kinase inhibitors and methods of use
|
JP5731978B2
(ja)
|
2008-09-26 |
2015-06-10 |
インテリカイン, エルエルシー |
複素環キナーゼ阻害剤
|
ES2570429T3
(es)
|
2008-10-16 |
2016-05-18 |
Univ California |
Inhibidores de heteroaril quinasa de anillo condensado
|
US8476431B2
(en)
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
WO2010068794A2
(en)
|
2008-12-10 |
2010-06-17 |
The General Hospital Corporation |
Hif inhibitors and use thereof
|
CA2760791C
(en)
|
2009-05-07 |
2017-06-20 |
Intellikine, Inc. |
Heterocyclic compounds and uses thereof
|
CN102574781B
(zh)
|
2009-09-30 |
2014-02-19 |
东丽株式会社 |
2,3-二氢-1h-茚-2-基脲衍生物及其药物用途
|
WO2011047384A2
(en)
|
2009-10-16 |
2011-04-21 |
The Regents Of The University Of California |
Methods of inhibiting ire1
|
ES2593256T3
(es)
|
2010-05-21 |
2016-12-07 |
Infinity Pharmaceuticals, Inc. |
Compuestos químicos, composiciones y métodos para las modulaciones de cinasas
|
CA2817577A1
(en)
|
2010-11-10 |
2012-05-18 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
DK2663309T3
(en)
|
2011-01-10 |
2017-06-19 |
Infinity Pharmaceuticals Inc |
METHODS FOR PRODUCING ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONES
|
TWI592411B
(zh)
|
2011-02-23 |
2017-07-21 |
英特爾立秦有限責任公司 |
激酶抑制劑之組合及其用途
|
US20140163075A1
(en)
*
|
2011-06-01 |
2014-06-12 |
Netherland Cancer Institute |
Modulation of the ubiquitin-proteasome system (ups)
|
MX2014000648A
(es)
|
2011-07-19 |
2014-09-25 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y sus usos.
|
AU2012284088B2
(en)
|
2011-07-19 |
2015-10-08 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
KR20140075693A
(ko)
|
2011-08-29 |
2014-06-19 |
인피니티 파마슈티칼스, 인코포레이티드 |
헤테로사이클릭 화합물 및 그의 용도
|
EP2751112B1
(en)
|
2011-09-02 |
2019-10-09 |
The Regents of The University of California |
Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
|
UY34539A
(es)
*
|
2011-12-23 |
2013-06-28 |
Millennium Pharm Inc |
Heteroarilos y usos de los mismos
|
US20150044178A1
(en)
|
2011-12-28 |
2015-02-12 |
Kyoto Prefectural Public University Corporation |
Normalization of culture of corneal endothelial cells
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
CN104995192A
(zh)
|
2012-09-26 |
2015-10-21 |
加利福尼亚大学董事会 |
Ire1的调节
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
AU2014235962A1
(en)
|
2013-03-20 |
2015-09-10 |
Aptose Biosciences Inc. |
2-substituted imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer
|
BR112015026519A2
(pt)
|
2013-04-19 |
2017-07-25 |
Astrazeneca Ab |
composto antagonista do receptor nk3 (nk3ra) para uso em um método destinado ao tratamento de síndrome do ovário policístico (sop)
|
DK3052102T3
(da)
|
2013-10-04 |
2020-03-09 |
Aptose Biosciences Inc |
Sammensætninger til behandling af cancere
|
NZ718430A
(en)
|
2013-10-04 |
2021-12-24 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds and uses thereof
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
CA2928626C
(en)
|
2013-11-14 |
2023-03-14 |
The Doshisha |
Drug for treating corneal endothelium by promoting cell proliferation or inhibiting cell damage
|
EA201691872A1
(ru)
|
2014-03-19 |
2017-04-28 |
Инфинити Фармасьютикалз, Инк. |
Гетероциклические соединения для применения в лечении pi3k-гамма-опосредованных расстройств
|
WO2015160975A2
(en)
|
2014-04-16 |
2015-10-22 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
US9708348B2
(en)
|
2014-10-03 |
2017-07-18 |
Infinity Pharmaceuticals, Inc. |
Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
|
US10669528B2
(en)
|
2015-06-25 |
2020-06-02 |
Children's Medical Center Corporation |
Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
|
CN114230571A
(zh)
|
2015-09-14 |
2022-03-25 |
无限药品股份有限公司 |
异喹啉酮的固体形式、其制备方法、包含其的组合物及其使用方法
|
EP3429603B1
(en)
|
2016-03-15 |
2021-12-29 |
Children's Medical Center Corporation |
Methods and compositions relating to hematopoietic stem cell expansion
|
WO2017161116A1
(en)
|
2016-03-17 |
2017-09-21 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
JP7054681B2
(ja)
|
2016-06-24 |
2022-04-14 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
組合せ療法
|
FR3060987B1
(fr)
*
|
2016-12-22 |
2020-10-02 |
Oreal |
Procede de coloration des fibres keratiniques mettant en oeuvre au moins un colorant triarylmethane particulier et au moins un colorant fluorescent
|
WO2019089511A1
(en)
|
2017-10-30 |
2019-05-09 |
Aptose Biosciences Inc. |
Aryl imidazoles for the treatment of cancer
|